Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2013
11/28/2013US20130317213 Hepatitis C Virus Inhibitors
11/28/2013US20130317077 Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317031 Nuclear Transport Modulators And Uses Thereof
11/28/2013US20130317029 Oxypyrimidines as syk modulators
11/28/2013US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013US20130317003 Histone Deacetylase Inhibitors
11/28/2013US20130317001 N-substituted benzamides and methods of use thereof
11/28/2013CA2875990A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/27/2013EP2665718A2 Improved process for preparation of high molecular weight molybdenum succinimide complexes
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665705A2 Improved process for preparation of low molecular weight molybdenum succinimide complexes
11/27/2013EP2665704A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
11/27/2013CN103415289A Pro-neurogenic compounds
11/27/2013CN103408536A Method for preparing ultraviolet ray absorption agent isocyanuric acid benzotriazole
11/27/2013CN103408535A Synthetic process of Almotriptan intermediate 5-bromo-3-(N-methyl pyrroline-2-methyl)-1H-indole
11/27/2013CN103408534A Novel synthetic process of Eletriptan
11/27/2013CN103406134A Aluminum oxide carrier solid alkali catalyst and preparation method thereof
11/27/2013CN102421754B Acrylamide derivative and use thereof in manufacture of medicament
11/27/2013CN101977900B 5-fluoro pyrimidine derivatives
11/27/2013CN101809012B Spiro substituted compounds as angiogenesis inhibitors
11/27/2013CN101765591B Pyrimidine derivatives useful for treatment of inflammatory or allergic conditions
11/26/2013US8592584 Compositions and methods including cell death inducers and procaspase activation
11/26/2013US8592582 Method for producing pyrimidinylpyrazole compounds
11/26/2013US8592475 Inhibitors of Akt activity
11/26/2013US8592437 Heteroarylamide pyrimidone compounds
11/26/2013US8592056 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
11/26/2013CA2623652C Antibody-drug conjugates and methods of use
11/26/2013CA2335240C Cyanine dyes and synthesis methods thereof
11/21/2013WO2013173811A1 Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof
11/21/2013WO2013173784A1 Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
11/21/2013WO2013173768A1 Process for making hydroxylated cyclopentylpyrimidine compounds
11/21/2013WO2013173736A1 Process for making hydroxylated cyclopentylpyrimidine compounds
11/21/2013WO2013173492A1 Antiviral compounds with an imidazole - biphenyl - imidazole core
11/21/2013WO2013173218A1 1,3-diaryl-substituted heterocyclic pesticides
11/21/2013WO2013172479A1 Carboxylic acid compounds
11/21/2013WO2013172255A1 Compound, light emitting material, and organic light emitting element
11/21/2013WO2013171690A1 Monocyclic heteroaryl cycloalkyldiamine derivatives
11/21/2013WO2013171642A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171639A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171318A1 Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013WO2013155483A8 Phototherapy devices and methods comprising optionally substituted quinquiesphenyl compounds
11/21/2013WO2012104206A9 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
11/21/2013US20130310565 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/21/2013US20130310427 Inhibitors of hcv ns5a protein
11/21/2013US20130310396 Thiazolidine derivatives and their therapeutic use
11/21/2013US20130310395 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013US20130310393 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310387 Monocyclic Heteroaryl Cycloalkyldiamine Derivatives
11/21/2013US20130310381 Substituted sodium-1h-pyrazole-5-olate
11/21/2013US20130310377 Novel modulators of calcium release-activated calcium channel
11/21/2013US20130310376 2-aryl-4-quinazolinones and their pharmaceutical compositions
11/21/2013US20130310365 Cyclohexyl-azetidinyl antagonists of ccr2
11/21/2013US20130310358 Pyrimidine compounds as delta opioid receptor modulators
11/21/2013US20130309272 Compounds for inflammation and immune-related uses
11/21/2013US20130309195 Antiviral compounds
11/20/2013EP2664618A2 Chemokine receptor modulators
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2663565A2 Heteroaryl compounds and methods of use thereof
11/20/2013EP2663550A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2414348B1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2403832B1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/20/2013EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease
11/20/2013EP2007747B1 Process for preparing heterocyclic derivatives
11/20/2013EP1809624B1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/20/2013EP1709009B1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
11/20/2013EP1572199B1 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
11/20/2013CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
11/20/2013CN103402997A Diaminopyrimidine derivatives and processes for the preparation thereof
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402995A Novel indole or indazole derivative or salt thereof
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402985A Microbiocidal pyrazole derivatives
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/20/2013CN103396408A Preparation method of impurity B in candesartan cilexetil
11/20/2013CN103396407A Preparation method of candesartan cilexetil crystal
11/20/2013CN103396406A Preparation method of candesartan cilexetil
11/20/2013CN103396405A Benzimidazole-4-formamide derivate with PARP (poly-ADP-ribose polymerase) inhibiting effect
11/20/2013CN103396404A Compound using triphenylpyrimidine as core as well as preparation method and application thereof
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396398A Prokineticin 1 receptor antagonists
11/20/2013CN103396351A Pyrrolidone Bc1-2 protein small-molecule inhibitor compound, and preparation, pharmaceutical composition and pharmaceutical use thereof
11/20/2013CN102617554B Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof
11/20/2013CN102421771B Pyridinone amide derivatives, preparation methods and medical uses thereof
11/20/2013CN102015680B New substituted indolin-2-one derivatives and use thereof as p38 mitogen-activated kinase inhibitors
11/20/2013CN101605779B Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
11/19/2013US8586600 Heterocyclic compounds and uses thereof
11/19/2013US8586599 Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
11/19/2013US8586588 Aryl pyridazinone derivatives and their use as H3 receptor ligands
11/19/2013US8586577 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
11/19/2013US8585938 UV-absorbers for ophthalmic lens materials
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2446620C Antiviral nucleosides
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 626